NextGen MES platform for pharmaceutical manufacturing with AI-powered capabilities, cloud-native Track & Trace, Electronic Batch Records, and comprehensive GMP compliance designed exclusively for pharma operations by a 100% pharma-focused company.
Körber PAS-X MES is a comprehensive Manufacturing Execution System designed exclusively for pharmaceutical manufacturing operations. Developed by Körber Pharma, a 100% pharma-focused company based in Hamburg, Germany, PAS-X MES represents over 20 years of pharmaceutical domain expertise since the company's founding in 2004.
In March 2025, Körber launched the NextGen MES platform with AI-powered capabilities and cloud-native Track & Trace functionality, bringing advanced analytics and machine learning to production operations while maintaining compliance with FDA 21 CFR Part 11 and GMP regulations.
The platform provides complete production orchestration including Electronic Batch Records (EBR), Master Batch Records, recipe management, material management, equipment integration, and real-time production monitoring. PAS-X MES integrates with Körber's broader pharma ecosystem including packaging, inspection, and Track & Trace solutions, providing end-to-end manufacturing visibility.
Körber names Johnson & Johnson, Sanofi and Merck KGaA as PAS-X customers in its press releases and case studies. Roche and GlaxoSmithKline are named in Körber material as well, though neither is corroborated as a PAS-X customer independently of Körber. Eurofarma in Brazil became the first national pharmaceutical company to implement PAS-X.
The platform has a 4.4/5 star rating on Gartner Peer Insights based on 65 reviews of the PAS-X MES Suite listing. Users highlight the pharma-specific design, comprehensive functionality, and strong regulatory compliance support as key differentiators.
The platform targets mid-to-large pharmaceutical manufacturers with complex production operations requiring GMP-compliant MES capabilities.
Körber PAS-X MES is designed exclusively for pharmaceutical manufacturing - the product and company are 100% pharma-focused with tagline "Delivering the difference in pharma"
Körber PAS-X MES offers flexible deployment options including cloud-native deployment (NextGen MES launched March 2025), on-premise installation, and hybrid configurations. The NextGen MES platform emphasizes cloud-native architecture with AI-powered capabilities and modern microservices design.
The platform integrates with equipment from multiple vendors, ERP systems, quality management systems, and Körber's broader pharma solutions ecosystem including packaging, inspection, and serialization systems. Native integration with Track & Trace systems provides end-to-end supply chain visibility.
The NextGen MES includes AI capabilities for production optimization, predictive analytics, and anomaly detection. Cloud-native architecture enables scalability and modern deployment patterns while maintaining the strict regulatory compliance requirements of pharmaceutical manufacturing.
Equipment integration supports major automation vendors and process control systems. The platform provides REST APIs for custom integrations and data exchange with enterprise systems.
Körber PAS-X MES pricing is not publicly disclosed and follows an enterprise pricing model based on manufacturing site size, number of users, production lines, and configuration requirements. Pricing is available by contacting Körber Pharma sales.
Implementation services, validation support, and ongoing platform maintenance are additional components to the license cost. Product demos are available on request.
Typical deal size and per-user pricing are not publicly disclosed. Free trial availability is undisclosed.
Körber PAS-X MES implementation includes platform configuration, workflow setup, equipment integration, ERP integration (if applicable), user training, and validation support for GxP environments. Typical implementation timeline is 6-12 months for mid-to-large pharmaceutical manufacturing operations.
Körber provides comprehensive validation documentation and support for FDA 21 CFR Part 11 and GMP compliance.
Implementation services include site assessment, requirements analysis, system configuration, integration with existing equipment and enterprise systems, user training, and go-live support. Migration from legacy MES systems is supported with data migration tools and transition planning.
As part of the Körber Pharma ecosystem, PAS-X MES can integrate with other Körber solutions for packaging, inspection, and Track & Trace, providing coordinated implementation across multiple manufacturing systems.
Anonymous feedback from pharmaceutical professionals using this solution
4.4 out of 5
Based on 11 verified reviews
Users describe PAS-X as "modular and flexible," well-suited for pharma and biotech, with the FIT-BUILD-RUN methodology and Content Suite templates praised as differentiators in regulated batch manufacturing. Exception handling for EBR is repeatedly cited as "the easiest in all the MES softwares available." Standard integrations to L2 automation, SAP, and LabWare LIMS via the certified PAS-X MSI Plug & Produce ecosystem are praised. Vendor reports 98% right-first-time across the installed base and 30-50% throughput uplift with PAS-X MES 3.4 multi-instance.
Pricing is the most frequent complaint - PAS-X is "on the more expensive side" and the per-adapter licensing scheme is criticized as "stretching the end-user's budget." Users describe the system as "rigid" outside supplied configuration surfaces, the UI as needing more responsiveness and "hard to use for newbies," and the learning curve as steep. Installations and upgrades "require quite a bit of overhead" - Boehringer Ingelheim Biberach migrated 3,500 MBRs from PAS-X V2 to V3.2. Advanced analytics and AI capabilities are reported as underdeveloped, and legacy machinery integration may require additional middleware.
Share your experience with Körber PAS-X MES anonymously. Your insights help pharmaceutical professionals make better software decisions.
Contribute Anonymous FeedbackPublicly disclosed pharmaceutical and biotech organizations
Jump to section